Endurant Capital Management LP raised its stake in shares of Insmed Incorporated (NASDAQ:INSM – Get Rating) by 125.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 243,122 shares of the biopharmaceutical company’s stock after acquiring an additional 135,409 shares during the quarter. Insmed makes […]
First Light Asset Management LLC decreased its position in Insmed Incorporated (NASDAQ:INSM – Get Rating) by 1.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 748,970 shares of the biopharmaceutical company’s stock after selling 7,447 shares during the period. Insmed makes up 1.4% of First Light Asset Management LLC’s investment portfolio, making the […]
StockNews.com upgraded shares of Insmed (NASDAQ:INSM – Get Rating) from a sell rating to a hold rating in a research report sent to investors on Thursday. INSM has been the subject of a number of other reports. HC Wainwright reaffirmed a buy rating and issued a $52.00 target price on shares of Insmed in a […]
Tang Capital Management LLC decreased its stake in shares of Insmed Incorporated (NASDAQ:INSM – Get Rating) by 66.8% during the fourth quarter, HoldingsChannel.com reports. The firm owned 166,203 shares of the biopharmaceutical company’s stock after selling 333,797 shares during the period. Tang Capital Management LLC’s holdings in Insmed were worth $3,321,000 at the end of […]
Saltoro Capital LP trimmed its holdings in Insmed Incorporated (NASDAQ:INSM – Get Rating) by 99.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,400 shares of the biopharmaceutical company’s stock after selling 2,994,600 shares during the quarter. Insmed accounts for approximately 0.1% […]